InCarda Therapeutics featured in FierceBiotech News
InCarda Therapeutics and our President & CEO Grace Colón were featured in a recent post on Endpoints News. The post highlights InCarda’s Raise of $30 Million Through First Close of Series C Equity Financing. More information below:
“What we’re doing is a completely new way of treating these patients. We hope to reduce the burden of the disease by limiting the total time a patient is in the state of arrhythmia at any given year. And by doing this, we hope we can dramatically change the course of the disease, the quality of life of patients, and actually greatly reduce health costs in the U.S.”
Grace E. Colón, Ph.D.
President & Chief Executive Officer